Neogen Chemicals
Stock Snapshot
Price Performance
Vista Outlook
Basis of our Recommendation
Neogen Chemicals is navigating a pivotal transition towards high-growth battery materials while maintaining its core specialty chemicals business. Management's recent commentary highlights a strategic pivot to capitalize on domestic demand for battery materials, particularly through the scaling of electrolyte and salt production. This shift is expected to enhance revenue growth and improve margins, supported by the commissioning of new facilities and a focus on proprietary technology to reduce reliance on Chinese supply chains. Vista's financial outlook reflects an anticipated acceleration in revenue growth beyond historical trends, with margins expected to improve as the company optimizes its product mix. However, challenges such as geopolitical tensions and global pricing pressures in the chemical industry remain pertinent. Over the next 12-24 months, key opportunities include the successful ramp-up of battery chemical production and the realization of benefits from recent capital investments. Conversely, watchpoints include execution risks associated with new facility stabilization and the need for high utilization rates among domestic cell OEMs. Overall, Neogen's strategic focus positions it well for future growth, with an expected upside of approximately 8.6%
Why We Like This Stock
- Strategic pivot towards battery materials is expected to drive revenue growth and improve margins
- Successful commissioning of new facilities will enhance production capacity and operational efficiencies
- Management's focus on reducing dependency on Chinese supply chains positions Neogen as a critical local partner for global manufacturers
Things To Watch Out For
- Execution risks related to the stabilization of new, large-scale facilities could impact growth
- Geopolitical tensions and global pricing pressures may exert margin pressures
- High working capital requirements and temporary overheads from plant rebuilds could affect near-term performance
Key Parameters
Financial Snapshot
View Technicals Analysis →| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 691 | 778 | 862 | 978 | 1,200 |
| Profit Before Tax (Cr.) | 53 | 64 | 41 | 57 | 72 |
| PBT Margin | 7.7% | 8.2% | 4.8% | 5.9% | 6.0% |
| Net Profit (Cr.) | 41 | 38 | 23 | 43 | 54 |
| Earnings Per Share | 14.9 | 14.0 | 8.4 | 15.7 | 19.8 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| IDBI Capital | ▲ Buy | 2,501 | 29-Jul-2026 |
| Kotak Securities | ► Add | 2,190 | 28-Jul-2026 |
Company Overview
Show Company Profile
Neogen Chemicals Limited engages in the manufacture and sale of specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds comprising unsaturated bromine derivatives, bromo hydroxy derivatives, and other compounds; and organo lithium compounds, including n-butyl lithium, lithium hexamethyldisilazide, lithium tetrahydride borate, lithium diisopropylamide, lithium tri-(t-butoxy) aluminium hydride, hexyl lithium, methyl lithium, and phenyl lithium. The company also provides inorganic chemicals comprising inorganic bromine compounds and lithium salts; grignard reagents; advance intermediates; and chemistries, such as alkylation, amination, oxidation, dehalogenation, silylation, anhydrous HF and HBr reactions, halex reaction, suzuki coupling, hydrogenation, and biocatalysis. It serves pharmaceuticals, agrochemicals, electronics, water treatment, construction, polymers, flavours & fragrances and energy storage. The company also exports its products to 36 countries. Neogen Chemicals Limited was incorporated in 1989 and is based in Thane, India.